Propel Bio Partners L.P. — Form D/A
Propel Bio Partners L.P. of LOS ANGELES, CA, a pooled investment fund, filed a Form D amendment with the SEC on 2023-03-15. The offering totals $150.0M, of which $39.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-03-15
- Form: D/A
- Accession: 0001917402-23-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $150.0M
- Amount sold: $39.0M
- Remaining: $111.0M
- Investors: 14
- Date of first sale: 2022-05-04
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-437849
Issuer
- Name: Propel Bio Partners L.P.
- CIK: 0001917402
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 1800 AVENUE OF THE STARS, 3RD FLOOR, LOS ANGELES, CA, 90067
- Phone: 206-602-9246
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Leen Kawas | Director | Los Angeles, CA |
| a Delaware Limited Liability Company PBP Partners LLC. | Director | Los Angeles, CA |
Other filings by this issuer (1)
More